Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,822,648 papers from all fields of science
Search
Sign In
Create Free Account
blonanserin
Known as:
2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine
, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (2)
AD 5423
lonasen
Broader (2)
Piperazines
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Retraction: ‘Effect of blonanserin on cognitive function in antipsychotic‐naïve first‐episode schizophrenia’
Tomomi Tenjin
,
S. Miyamoto
,
+13 authors
N. Yamaguchi
Human psychopharmacology
2017
Corpus ID: 19089245
The above article from Human Psychopharmacology, first published on 25 January 2012 in Wiley OnlineLibrary (onlinelibrary.wiley…
Expand
Review
2016
Review
2016
The outcome of paliperidone palmitate in schizophrenia The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder in patients with…
Han-Yong Jung
,
Sung-Wan Kim
,
+7 authors
Jin-Sang Yoon
2016
Corpus ID: 207835159
Objective: This study is to evaluate the efficacy, functional improvements, and insight improvements in schizophrenic patients…
Expand
Review
2015
Review
2015
Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
Y. Mizuki
,
M. Takaki
Journal of Clinical Psychopharmacology
2015
Corpus ID: 31160680
To the Editors: QT prolongation is reported to induce ventricular tachyarrhythmia and torsade de pointes. Psychiatric patients…
Expand
2015
2015
Blonanserin Induced Hypokinesia and Tardive Dyskinesia
G. Saraswathy
,
H. Virupaksha
,
G. Thejaswi
,
A. Lakshminarayan
2015
Corpus ID: 79303493
A 27 year old male diagnosed with psychosis, who was treated with Risperidone followed by aripiprazole was reported to present…
Expand
2014
2014
A NEW STABILITY INDICATING QUANTITATIVE RP-HPLC METHOD FOR BLONANSERIN-A NOVEL ANTIPSYCHOTIC AGENT
P. Mondal
,
S. Shobharani
,
R. Ramakrishna
2014
Corpus ID: 62837661
Article history The present research work describe a rapid, simple, validated and stability indicating RP- HPLC method for…
Expand
2012
2012
Blonanserin in management of Schizophrenia
R. Ghosh
2012
Corpus ID: 74652701
Schizophrenia was the seventh leading cause of life years lived with disability worldwide in 2000, according to WHO estimates.1…
Expand
2012
2012
Dystonia Secondary to Use of Antipsychotic Agents
Nobutomo Yamamoto
,
T. Inada
2012
Corpus ID: 30716817
Following the introduction of first-generation antipsychotics (FGAs) in the early 1950s, there was a radical change in the…
Expand
2011
2011
A simple and validated reverse phase HPLC method for the determination of Blonanserin in pharmaceutical dosage forms
Gunjan M. Modi
,
K. Chandrul
2011
Corpus ID: 38048244
A Simple and rapid reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated for…
Expand
2009
2009
Synthesis of Blonanserin
Hui-Ling-Shi-Hui-Ling Shi
2009
Corpus ID: 102211397
4-Fluorobenzoylcatonitrile,which was synthesized from methyl 4-fluorobenzoate and acetonitrile,reacted in the presence of…
Expand
2009
2009
2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine (blonanserin, Blonanserin) and composition thereof
Qing Lu
2009
Corpus ID: 103560556
The invention relates to a crystal of 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine…
Expand